What are the studies included in the review of Mineralocorticoid receptor antagonists (MRAs) in people with heart failure with reduced ejection fraction (HFREF)?
Four studies (reported in 13 papers) were included in the review: Eplerenone in Mild Patients Hospitalization and Survival Study, EMPHASIS-HF in Japanese patients (J-), Randomized Aldactone Evaluation Study (RALES) 268, 350, 351 and Udelson 2010 345.